Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04MYC
|
|||
Former ID |
DIB012374
|
|||
Drug Name |
NSC-625487
|
|||
Synonyms |
1-(2,6-Difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Investigative | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
C15H10F2N2S
|
|||
Canonical SMILES |
C1C2=NC3=CC=CC=C3N2C(S1)C4=C(C=CC=C4F)F
|
|||
InChI |
1S/C15H10F2N2S/c16-9-4-3-5-10(17)14(9)15-19-12-7-2-1-6-11(12)18-13(19)8-20-15/h1-7,15H,8H2
|
|||
InChIKey |
AMLBAOPYPUXEQF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 138226-12-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Human immunodeficiency virus Reverse transcriptase (HIV RT) | Target Info | Inhibitor | [1], [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors. Antivir Chem Chemother. 1999 Jul;10(4):211-7. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.